Saturday, September 5, 2009

When Health Care Gets Ugly - Pfizer to Pay $2.3 Billion for Fraudulent Marketing of Bextra-

Health care should be a field that gains the trust of the public for better quality of life. However, when comes to the line between ethics and profits, people tend to become greedy... money is the thing they choose in the end and people lives being put in danger...

Here's the excerpt of the news...

"WASHINGTON – American pharmaceutical giant Pfizer have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products..."

"...a felony violation of the Food, Drug and Cosmetic Act for misbranding Bextra with the intent to defraud or mislead. Bextra is an anti-inflammatory drug that Pfizer pulled from the market in 2005..."

"In addition, Pfizer has agreed to pay $1 billion to resolve allegations under the civil False Claims Act that the company illegally promoted four drugs – Bextra; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug – and caused false claims to be submitted to government health care programs for uses that were not medically accepted indication..."

"Illegal conduct and fraud by pharmaceutical companies puts the public health at risk, corrupts medical decisions by health care providers, and costs the government billions of dollars," said Tony West, Assistant Attorney General for the Civil Division."
(Full text of news here)

From another website, here's the excerpt...

"The FDA rejected a company application to market the drug for uses like that because the benefits didn't outweigh the risks, mainly cardiovascular problems. Bextra was approved to relieve arthritis pain (10 milligrams once a day) and menstrual pain (20 milligrams twice a day). But Pfizer touted Bextra heavily for other conditions and at higher doses anyway..."

"...encouraging doctors to start patients at high doses of Bextra--eight times the approved starting dose in the case of migraine patients..."
(Full text here)

No comments:

Post a Comment